Tag: tumors
Transgene and BioInvent’s BT-001 Oncolytic Virus Shows Promising Antitumor Activity in Ongoing Phase I/IIa Study in Resistant Solid Tumors
[ad_1] By Hector Chaunu Published on 09/16/2024 at 07:13 (Boursier.com) — Transgene a biotechnology company that designs…
Transgene and BioInvent’s BT-001 Oncolytic Virus Shows Promising Antitumor Activity in Ongoing Phase I/IIa Study in Resistant Solid Tumors – 09/14/2024 at 09:05
[ad_1] First clinical data presented at ESMO 2024 show that BT-001 induces tumor size reduction in patients with treatment failure In a patient with heavily pretreated sarcoma, BT-001 has the…
Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments – 09/14/2024 at 09:05
[ad_1] Preliminary data presented at ESMO 2024 demonstrate that BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatment In a patient with a heavily pretreated leiomyosarcoma, BT-001 was…
Medincell to Present Data Showing Improved Potential of a Monoclonal Antibody Against Melanoma Tumors Using BEPO® Technology – 07/01/2024 at 5:45 p.m.
[ad_1] Medincell will present its R&D advances based on its long-acting injectable technologies at the CRS 2024 conference, taking place July 8-12 in Bologna, Italy, including: • Oncology: presentation of…
Health: certain progestin hormones cause brain tumors, according to an ANSM study
[ad_1] Yasmina Kattou // Photo credit: LOIC VENANCE / AFP 06:52, March 29, 2024 According to a study by the National Agency for the Safety of Medicines and Health Products,…
This type of contraception increases the risk of brain tumors, study finds
Long-term use of progestins may increase the risk of developing a brain tumor, a new study suggests. Here’s what you need to know. IUD, pill, implant, patch… today there are…
OSE Immunotherapeutics: new positive results against advanced solid tumors
[ad_1] (AOF) – OSE Immunotherapeutics presents the latest positive results from the Phase 1/2 clinical evaluation of its product OSE-279 in advanced solid tumors at the 2024 ESMO Targeted Anticancer…
OSE Immunotherapeutics: positive results against solid tumors
[ad_1] (AOF) – OSE Immunotherapeutics announces the presentation of the first phase 1 clinical results of BI 770371, a new anti-SIRPα monoclonal antibody evaluated in solid tumors, at the ESMO…
TME Pharma: positive results in brain tumors – 06/30/2023 at 18:02
[ad_1] (CercleFinance.com) – TME Pharma announced on Wednesday that a study had shown that 83% of patients with glioblastoma, a brain cancer, were still alive after 15 months of treatment,…
TME Pharma: positive results in brain tumors
[ad_1] (CercleFinance.com) – TME Pharma announced on Wednesday that a study had shown that 83% of patients with glioblastoma, a brain cancer, were still alive after 15 months of treatment,…
TME Pharma: Positive results in brain tumors
[ad_1] (CercleFinance.com) – TME Pharma announced on Wednesday that a study had shown that 83% of patients with glioblastoma, a brain cancer, were still alive after 15 months of treatment,…
when mushrooms put us on the trail of cancerous tumors
Could the screening of fungi present in the human body be part of the future markers used in the diagnosis or prognosis of cancers? This new field of research is…